Regulatory Due Diligence

In today’s evolving development landscape, there is no “one size fits all” solution. So it’s critical to stay alert and gather objective, reliable information prior to making decisions. Good due diligence of potential products – for development or acquisition – requires an understanding of what really matters. Cmed has the essential experience in competitive pharma/biotech markets, operations and business development strategy – as well as business analysis and technical and scientific expertise. With us, you know what you’re getting into and where the risks may be.

 

How we helped an established European pharmaceutical company:

> Conducted an opportunity assessment of a reformulation of a marketed 
    biologic.

> Quantified the market opportunity.

> Assessed the market positioning and USPs of the target product.

> Reviewed the competitive environment, assessing sales and pricing of
   competitor products (based on IMS data).

> Compiled likely competitive responses by entrenched players in the market.

 

The result? Solid insights to chart the best course forward.